{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:58:54Z","timestamp":1773694734562,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jmgm.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T02:30:55Z","timestamp":1500517855000},"page":"364-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Investigation of novel pharmacological chaperones for Gaucher Disease"],"prefix":"10.1016","volume":"76","author":[{"given":"Buge","family":"Yilmazer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. Begum","family":"Yagci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Ozden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutlu","family":"Ulgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Ozkirimli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2017.07.014_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid \u03b2-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0010","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0015","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0025","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/hmg\/ddu299","article-title":"Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins","volume":"23","author":"Motta","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1098\/rstb.2003.1271","article-title":"Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease","volume":"358","author":"Moyses","year":"2003","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage DisordersIdentification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0040","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"The effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0050","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.13052","article-title":"Disease models for the development of therapies for lysosomal storage diseases","volume":"1371","author":"Xu","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0060","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0065","first-page":"159","article-title":"Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease, Blood Cells","volume":"42","author":"S\u00e1nchez-Oll\u00e9","year":"2009","journal-title":"Mol. Dis."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0070","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid \u03b2-glucosidase: insights into the mechanism of chemical chaperone action in gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0075","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase","volume":"9","author":"Kornhaber","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0080","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.bmc.2011.04.011","article-title":"Docking and SAR studies of D- and L-isofagomine isomers as human \u03b2-glucocerebrosidase inhibitors","volume":"19","author":"Kato","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0085","first-page":"219","article-title":"N-Octyl-\u03b2-valienamine up-regulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"2004","author":"Lin","year":"1689","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0090","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/c2ob06987c","article-title":"Synthesis of N-substituted \u03b2-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease","volume":"10","author":"Wang","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/cbic.201300197","article-title":"New insights into the pharmacological chaperone activity of C2-Substituted glucoimidazoles for the treatment of gaucher disease","volume":"14","author":"Li","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0100","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/jm300342q","article-title":"Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease","volume":"55","author":"Trapero","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0105","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1021\/jm101204u","article-title":"New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening","volume":"54","author":"D\u00edaz","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0110","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/cbic.201000192","article-title":"Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones","volume":"11","author":"Schitter","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0115","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1039\/C5OB02223A","article-title":"Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease","volume":"14","author":"Kato","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmgm.2015.11.004","article-title":"A systematic methodology for large scale compound screening: a case study on the discovery of novel S1PL inhibitors","volume":"63","author":"Deniz","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0125","unstructured":"Maestro, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0130","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"Bento","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0135","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gkr320","article-title":"ChemMine tools: an online service for analyzing and clustering small molecules","volume":"39","author":"Backman","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0140","unstructured":"Phase, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE. a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0155","unstructured":"LigPrep, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0160","unstructured":"ConfGen, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/ci100015j","article-title":"ConfGen. A conformational search method for efficient generation of bioactive conformers","volume":"50","author":"Watts","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0170","unstructured":"Schr\u00f6dinger Suite 2015-4 Protein preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2015; Impact, Schr\u00f6dinger, LLC, New York, NY, 2015; Prime Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0180","unstructured":"Glide, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0185","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0190","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0195","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/ci900212v","article-title":"Novel method for generating structure-based pharmacophores using energetic analysis","volume":"49","author":"Salam","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","article-title":"Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation","volume":"23","author":"Loving","year":"2009","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0205","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC. A free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0215","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2010.08.004","article-title":"Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation","volume":"15","author":"Abad-Zapatero","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0220","unstructured":"QikProp, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0225","unstructured":"Canvas, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","article-title":"Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods","volume":"29","author":"Duan","year":"2010","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ci100062n","article-title":"Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments","volume":"50","author":"Sastry","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an induced fit receptor structure in virtual screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0245","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0250","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0255","unstructured":"Schr\u00f6dinger Suite 2015-4 Induced Fit Docking protocol; Glide, Schr\u00f6dinger, LLC, New York, NY, 2015; Prime, Schr\u00f6dinger, LLC, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1875397301004010067","article-title":"High throughput screening for inhibitors of alpha-Galactosidase","volume":"4","author":"Motabar","year":"2010","journal-title":"Curr. Chem. Genomics"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0270","unstructured":"Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2015. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY (2015)."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0275","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0280","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1747-0285.2010.00951.x","article-title":"Probing the \u03b1-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis","volume":"75","author":"Guo","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0285","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006","journal-title":"SC 2006 Conf. Proc. ACM\/IEEE"},{"key":"10.1016\/j.jmgm.2017.07.014_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.10.004","article-title":"Rapid preparation of (3R, 4S, 5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease","volume":"126","author":"Cheng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0295","first-page":"S123","article-title":"Rapid synthesis of pyrrolidine-based iminosugars to develop pharmacological chaperones for disease","volume":"114","author":"Wang","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0300","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pharma.2014.02.002","article-title":"Synthesis and in silico studies of pyrrolidine sulfonamide based dipeptides as \u03b2-gluscosidase inhibitors","volume":"72","author":"Santosh Kumar","year":"2014","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00044-012-0004-3","article-title":"Synthesis, characterization, and pharmacological evaluation of 1-[2-(6-nitro-4-oxo-2-phenyl-4H-quinazolin-3-yl)-ethyl]-3-phenyl ureas","volume":"22","author":"Rana","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0310","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/14756366.2010.504674","article-title":"Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines","volume":"26","author":"Tanarro","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0315","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1021\/jm100524j","article-title":"Synthesis and biological activity of pyrido[3\u2032,2\u2032:4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors","volume":"53","author":"Taltavull","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bmcl.2008.11.093","article-title":"Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors","volume":"19","author":"Zhao","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0325","unstructured":"R. Hohlweg, F.Z. D\u00f6rwald, H. Stephensen, I. Pettersson, B. Peschke, Novel aryl- and heteroarylpiperazines, WO2003066604 A2, 2003."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0330","unstructured":"M. Hansen, Antimetastic compounds, WO2012027392 A3, 2012."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0335","unstructured":"J.T. Brnardic, J. Edward, Mark E. Fraley, Robert M. Garbaccio, Steen, Inhibitors of checkpoint kinases, WO2006074281 A2, 2006."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0340","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10719-016-9661-7","article-title":"Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase","volume":"33","author":"Pol-Fachin","year":"2016","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jmgm.2017.07.014_bib0350","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317302413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317302413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:57:30Z","timestamp":1761080250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326317302413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":70,"alternative-id":["S1093326317302413"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.07.014","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of novel pharmacological chaperones for Gaucher Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}